Noticias de REVB_US

Noticias del mercado

Últimas noticias sobre REVB_US — 153 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: REVB_US ✕ 153 resultados
03/06/2026 REVB_US — The Newark Advocate
Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, CA / ACCESS Newswire / 12 de enero de 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (la "Compañía" o

01/06/2026 REVB_US — Investing.com Nigeria
Revelation Biosciences expands AKI advisory board By Investing.com
01/06/2026 REVB_US — The Joplin Globe ES ← EN
Revelation Biosciences amplía el consejo asesor sobre lesiones renales agudas

Revelation Biosciences Expands Acute Kidney Injury Advisory Board

01/06/2026 REVB_US — Rutland Herald
Revelation Biosciences Expands Acute Kidney Injury Advisory Board
01/06/2026 REVB_US — Corsicana Daily Sun ES ← EN
Revelation Biosciences amplía el consejo asesor sobre lesiones renales agudas

Revelation Biosciences Expands Acute Kidney Injury Advisory Board

01/06/2026 REVB_US — newswire.com ES ← EN
Revelation Biosciences amplía el consejo asesor sobre lesiones renales agudas

Revelation Biosciences Expands Acute Kidney Injury Advisory Board

01/06/2026 REVB_US — Stock Titan
Revelation Biosciences (NASDAQ: REVB) furnishes new corporate presentation
01/06/2026 REVB_US — Investing.com
Revelation Biosciences expands AKI advisory board
01/06/2026 REVB_US — TradingView
Revel Releases Updated Corporate Presentation and Posts It to Website

Revel publicó una presentación corporativa actualizada y la puso a disposición del público en su sitio web. Aspectos destacados clave: Presentación original ante la SEC: REVELATION BIOSCIENCES, INC. [ REVB ] - 8-K - 01 de junio de 2026 Este es un resumen impulsado por IA. Puede contener imprecisiones. Considere verificar información importante con...

29/05/2026 REVB_US — newsline.com
REVB Q1 2026 Earnings: Wider-Than-Expected Loss Highlights Pre-Revenue Stage - Subscription Growth Report
29/05/2026 REVB_US — newsline.com
Revelation Biosciences (REVB) Shows Minimal Movement as Shares Trade Near Key Support - Time Weighted Price
29/05/2026 REVB_US — newsline.com
Revelation Biosciences (REVB) Shows Minimal Movement as Shares Trade Near Key Support - ETF Creation Redemption
29/05/2026 REVB_US — MarketBeat ES ← EN
Precio de acciones, noticias y análisis de Revelation Biosciences (REVB)

Revelation Biosciences (REVB) Stock Price, News & Analysis

28/05/2026 REVB_US — thelegaladvocate.com ES ← EN
Ganancias de REVB en el primer trimestre de 2026: pérdida significativa de EPS a medida que continúa el consumo de efectivo sin ingresos: rentabilidad de los activos

REVB Q1 2026 Earnings: Significant EPS Miss as Cash Burn Continues Without Revenue - Return On Assets

28/05/2026 REVB_US — newsline.com
REVB Q1 2026 Earnings: Significant EPS Miss as Cash Burn Continues Without Revenue - Profit Recovery Report
27/05/2026 REVB_US — The Legal Advocate
Revelation Biosciences (REVB) Inches Higher, Holding Above Key Support at $1.02 - Bear Pennant
27/05/2026 REVB_US — newsline.com
Revelation Biosciences (REVB) Inches Higher, Holding Above Key Support at $1.02 - Upthrust Pattern
27/05/2026 REVB_US — newsline.com
Revelation Biosciences (REVB) Inches Higher, Holding Above Key Support at $1.02 - Dividend Growth Stocks
27/05/2026 REVB_US — The Legal Advocate
REVB Q1 2026 Earnings: Significant EPS Miss Amid Early-Stage Development - Earnings Revision Downgrade
27/05/2026 REVB_US — The Legal Advocate
REVB Q1 2026 Earnings: Significant EPS Miss Amid Early-Stage Development - Management Tone Analysis

Página 2 de 8

keyboard_arrow_up